Stocksigma LogoStocksigma Logo

Rekvina Laboratories Board Approves Q2 Results and Appoints New Compliance Officer

Rekvina Laboratories Limited's Board of Directors approved the standalone and consolidated unaudited financial results alongside the limited review report

Rekvina Laboratories Board Approves Q2 Results and Appoints New Compliance Officer

Rekvina Laboratories Ltd 路 Outcome 路 13 Nov 2026, 11:11 pm

Rekvina Laboratories Board Approves Q2 Results and Appoints New Compliance Officer Rekvina Laboratories Limited's Board of Directors approved the standalone and consolidated unaudited financial results alongside the limited review report for the quarter and half-year ended 30th Sep'26 on 13th Nov'26. The board also reviewed the Regulation 32 statement on deviation or variation of funds. Additionally, Ms. Bhagyshree Manojbhai Kandoi was appointed as Company Secretary and Compliance Officer, effective 16th Nov'26.

Original exchange filing (PDF)

More announcements from Rekvina Laboratories Ltd

All Rekvina Laboratories Ltd announcements